Bug biscuits boost senior health? small study says maybe

NCT ID NCT07456319

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tested whether protein biscuits made from insect flour (Tenebrio molitor) could improve heart health in older adults when combined with exercise. Thirty people aged 60 and older ate either insect biscuits or regular biscuits after supervised workouts for 28 days. Researchers measured changes in cholesterol, blood pressure, body composition, and other health markers to see if this sustainable protein source offers benefits for aging.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

May 2024

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Eligibility Criteria Inclusion Criteria: * Age ≥ 60 years * Body mass index (BMI) between 18.5 and 30.0 kg/m² * Mini-Mental State Examination (MMSE) score ≥ 16 * Independent in basic activities of daily living * Mini Nutritional Assessment-Short Form (MNA-SF) score ≥ 8 * Ability to provide written informed consent Exclusion Criteria: * Food Neophobia Scale score \> 4 * Chronic diseases affecting metabolism or nutritional status * Dependency or severe functional impairment * Current or past use of medications or supplements affecting body weight or metabolic function * Excessive alcohol consumption * History of eating disorders or psychiatric illness * Known food allergies (e.g., crustacean allergy) or celiac disease * Inability or unwillingness to comply with study procedures

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aging are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Motor Activity nutritional disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • UOC

    Barcelona, Barcelona, 08018, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.